Dr. David Haybron

Dr. Ibrahim Sultan is a cardiac surgeon and is certified in general surgery by the American Board of Surgery and cardiothoracic surgery by the American Board of Thoracic Surgery. Dr. Sultan earned his medical degree from Cornell University and completed his residency in general surgery at the Johns Hopkins Hospital. He subsequently completed his residency in cardiothoracic surgery at the Hospital of the University of Pennsylvania, where he also served as an advanced fellow in thoracic aortic surgery and minimally invasive valve surgery. Dr Sultan serves as the Professor and Chief of Cardiac Surgery, the Executive Vice Chair of Cardiothoracic Surgery and Co-Director of the Heart and Vascular Institute at UPMC and the University of Pittsburgh School of Medicine. Dr. Sultan is rated as an Elite provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Aortic Dissection, Aortic Valve Stenosis, Thoracic Aortic Aneurysm, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Forozan Navid is a Thoracic Surgeon in Pittsburgh, Pennsylvania. Dr. Navid is rated as a Distinguished provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Aortic Dissection, Thoracic Aortic Aneurysm, Aortic Valve Stenosis, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

Dr. Kaczorowski’s clinical interests include cardiothoracic transplantation, durable and temporary mechanical circulatory support, and adult cardiac surgery. A specific area of clinical focus is minimally invasive left ventricular assist device (LVAD) insertion. Accordingly, Dr. Kaczorowski has provided training for this approach and has hosted surgeons from around the country interested in learning this technique. Clinical research interests include the application of minimally invasive approaches to LVAD insertion and optimizing outcomes patients undergoing LVAD insertion and cardiac transplantation. Dr. Kaczorowski’s clinical research efforts are also directed at improving clinical outcomes in patients supported on extracorporeal membrane oxygenation (ECMO) and other forms of temporary mechanical circulatory support. In addition to clinical research efforts, Dr. Kaczorowski also conducts translational research. His translational work has focused on the development of technology to facilitate endovascular access through extra-corporeal life support circuits and novel technology intended to reduce complications associated LVADs. Dr. Kaczorowski is rated as a Distinguished provider by MediFind in the treatment of Adenosine Deaminase 2 Deficiency. His top areas of expertise are Aortic Dissection, Cardiogenic Shock, Cystic Medial Necrosis of Aorta, Heart Transplant, and Heart Bypass Surgery.